Lia DeGroot

The EMA is urg­ing drug de­vel­op­ers to ap­pro­pri­ate­ly as­sess the risk of us­ing ar­ti­fi­cial in­tel­li­gence or ma­chine learn­ing in the drug de­vel­op­ment process and to

The House of Rep­re­sen­ta­tives passed its wide-reach­ing de­fense spend­ing bill Fri­day on a large­ly par­ty-line vote, green­light­ing a bi­par­ti­san pro­vi­sion that would di­rect the De­part­ment

The FDA on Thurs­day re­leased two new draft guid­ance doc­u­ments re­lat­ed to the man­u­fac­ture of cell and gene ther­a­pies, one di­rect­ing man­u­fac­tur­ers to car­ry out

FDA is award­ing $50 mil­lion to two promi­nent North Car­oli­na uni­ver­si­ties to es­tab­lish a reg­u­la­to­ry sci­ence re­search cen­ter — and the lat­est in­sti­tu­tion to re­ceive